title: Hawk tea (Litsea coreana Levl. var. lanuginose) attenuates CCl(4)-induced hepatic damage in Sprague-Dawley rats.
abstract: Hawk tea (Litsea coreana Levl. var. lanuginose) is a traditional Chinese drink similar to green tea. In the present study, the preventive effects of Hawk tea on hepatic damage induced by carbon tetrachloride (CCl(4)) were studied in Sprague-Dawley rats. Silymarin was used as a positive control. Hawk tea was successfully shown to prevent hepatic damage in the rats. Serum levels of AST, ALT and LDH were significantly decreased when the rats were treated with varying concentrations of Hawk tea compared with silymarin (P<0.05). The lowest enzyme activities were exhibited in the 400 mg/kg Hawk tea group. This group showed reduced levels of the serum proinflammatory cytokines IL-6, IFN-γ and TNF-α. In particular, the IFN-γ level decreased markedly compared with the other concentration groups. The histopathology sections of liver tissue in the 400 mg/kg Hawk tea group recovered well from the CCl(4) damage, but the sections of the other concentration groups showed necrosis to a more serious degree. Reverse transcription-polymerase chain reaction (RT-PCR) and western blot analyses of the inflammation-related genes iNOS, COX-2, TNF-α and IL-1β in the rat livers were tested. The 400 mg/kg Hawk tea group showed significantly decreased mRNA and protein expression levels of iNOS, COX-2, TNF-α and IL-1β compared with the control group. Accordingly, 400 mg/kg Hawk tea potentially contributes to the prevention of CCl(4)-induced hepatic damage in vivo. A 200 or 100 mg/kg dose of Hawk tea also demonstrated preventive effects against hepatic damage.
authors: Department of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067,  P.R. China.
authors: Xin
authors: X
authors: Zhao
keywords: CCl; Hawk tea; cytokines; hepatic damage; inflammation
references: Arch Biochem Biophys. 2007 Jun 15;462(2):132-9
references: 17321482
references: Biol Pharm Bull. 2003 Nov;26(11):1618-9
references: 14600413
references: J Hepatol. 2012 May;56(5):1080-1088
references: 22245896
references: J Matern Fetal Neonatal Med. 2010 Jan;23(1):96-102
references: 19658035
references: Eur J Gastroenterol Hepatol. 2001 Jul;13(7):777-84
references: 11474306
references: Int Immunopharmacol. 2008 Jun;8(6):836-44
references: 18442787
references: Scand J Immunol. 2011 Aug;74(2):135-43
references: 21449940
references: Biol Chem. 2006 Apr;387(4):349-60
references: 16606331
references: Surgery. 2005 Aug;138(2):134-40
references: 16153419
references: Expert Opin Drug Metab Toxicol. 2012 Jun;8(6):655-64
references: 22475359
references: J Appl Physiol (1985). 2004 Dec;97(6):2184-9
references: 15298985
references: Crit Rev Toxicol. 2003;33(2):105-36
references: 12708612
references: Mol Biol Rep. 1994 Mar;19(2):81-8
references: 8072494
references: Indian J Exp Biol. 2011 Dec;49(12):939-45
references: 22403868
references: Appl Microbiol. 1966 Jan;14(1):49-54
references: 5330680
references: World J Gastroenterol. 1999 Feb;5(1):38-40
references: 11819382
references: Indian J Exp Biol. 2009 Apr;47(4):257-63
references: 19382721
references: J Hepatol. 2007 Dec;47(6):826-33
references: 17923165
references: J Med Food. 2003 Winter;6(4):273-80
references: 14977434
references: Diabetes Res Clin Pract. 2005 Jul;69(1):29-35
references: 15955385
references: Indian J Exp Biol. 2008 Jul;46(7):514-20
references: 18807755
references: Br J Rheumatol. 1994 Oct;33(10):927-31
references: 7921752
references: Immunol Rev. 2000 Apr;174:160-71
references: 10807515
references: CRC Crit Rev Toxicol. 1973 Nov;2(3):263-97
references: 4357489
references: Food Chem Toxicol. 2012 Mar;50(3-4):1066-72
references: 22269903
references: Food Chem Toxicol. 2010 May;48(5):1255-61
references: 20170702
references: J Ethnopharmacol. 2010 Feb 17;127(3):777-80
references: 19874881
references: J Clin Gastroenterol. 2003 Oct;37(4):278-9
references: 14506381